An AI model for prostate MRI offered an 89 percent AUC for prostate cancer detection in external validation testing, according to a newly published international multicenter study.
|Articles|April 11, 2005
MSCT proves acceptable for selecting pancreatic cancer patients for surgery
Multislice CT is an acceptable alternative to endoscopic ultrasound for identifying which pancreatic lesions can be treated surgically, according to a study from Indiana University.
Advertisement
Multislice CT is an acceptable alternative to endoscopic ultrasound for identifying which pancreatic lesions can be treated surgically, according to a study from Indiana University.
Four-slice CT showed accuracy comparable to endoscopic ultrasound in detecting resectable pancreatic tumors, said lead author Dr. John DeWitt, an assistant professor of medicine at the IU School of Medicine.
In fact, a person having a high-quality CT scan showing a completely resectable mass can forgo endoscopic ultrasound for confirmation altogether, DeWitt said.
In a prospective study, DeWitt and colleagues examined 120 patients with confirmed or suspected pancreatic cancer. The subjects underwent endoscopic ultrasound followed by quadslice CT with dual-phase imaging. Results were published in the November issue of the Annals of Internal Medicine.
Of 80 patients with confirmed cancer, 66% qualified for surgery. Although endoscopic ultrasound was generally more accurate than MSCT for detection and staging, the differences were not significant enough to win DeWitt's support for the modality for assessing disease resectability.
Ultrasound scored a 98% accuracy rate for detecting pancreatic tumors, compared with 86% accuracy for MSCT, and ultrasound staging was 67% accurate, compared with a dismal 41% for MSCT. However, only four percentage points separated ultrasound's 92% accuracy rate for identifying viable tumor candidates and the 88% rate for MSCT. Additionally, MSCT correctly identified 64% of the 28 unresectable tumors compared with 68% for ultrasound.
The noninvasiveness of MSCT is a big advantage, according to DeWitt. It does not require sedation or the insertion of an endoscope, making the technique less invasive than endoscopic ultrasound and more attractive for determining lesion resectability.
"MSCT should be the initial test of choice in patients with suspected pancreatic cancer," he said.
Some of the limitations of the study included a small sample size and the fact that radiologists and sonographers were not blinded to previous radiographic information. Further comparative studies using 32- or 64-slice scanners with multiplanar reconstruction are needed, according to DeWitt.
For more information from the online Diagnostic Imaging archives:
Advertisement
Related to this article
In the latest episode of her Breast Imaging in Focus series, Manisha Bahl, MD, MPH, FSBI, discusses new research comparing mammography-based AI models for breast cancer detection and short-term risk prediction.
In a recent episode of our Molecular Imaging in Focus series, Jack Andrews, MD, discussed pertinent findings from a recent intra-patient comparative study of PSMA PET agents in men with recurrent prostate cancer presented at the recent ASTRO conference.
The use of adjunctive CT bone reading software in women with breast cancer detected between 8 to 22 percent more metastatic lesions for reviewing radiologists and reduced CT interpretation time by 50 percent or more, according to a new study.
Expert Radiology is a **radiologist-run teleradiology practice with 10 years of experience**, hiring teleradiologists earning **$500–$900/hr with per-dictation pay**. Work from anywhere with true flexibility, **no shifts, no call, and no weekends**.
Our case mix is **predominantly outpatient and noncontrast**, with approximately **75% MRI**, plus X-ray and CT.
We cover **malpractice with tail**, handle all medical licensing, and ship you a **$10K reading station with six vertical 4K monitors**.
Minimum commitment is an **average of 400 cases per month**.
**Book a call with Brandi Escapule, Principal, Physician Services.**
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.
While the allure of partnership or a hierarchical promotion system for those who paid their dues once sounded promising, the current reality amid declining reimbursements, thinning practice margins and private equity acquisitions is going after the gig with the most optimal lifestyle and paycheck.
Catch up on the top radiology content of the past week.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Breast Imaging in Focus: Can AI Models for Breast Cancer Detection and Risk Prediction Be Used Interchangeably?
2
What a Large Prostate MRI Study Reveals About AI and Unassisted Radiologist Assessment
3
Molecular Imaging in Focus: Comparative PSMA PET Study Offers Insights for Men with Recurrent PCa and Low PSA Values
4
Can CT Bone Reading Software Enhance Detection of Metastatic Rib Lesions in Women with Breast Cancer?
5